Konduri Kartik, Sahota Surinder S, Babbage Gavin, Tong Alex W, Kumar Padmasini, Newman Joseph T, Stone Marvin J
Baylor Charles A. Sammons Cancer Center, 3535 Worth Street, Dallas, TX 75246, USA.
Clin Lymphoma. 2005 Mar;5(4):285-9. doi: 10.3816/clm.2005.n.018.
Immunoglobulin (Ig) M myeloma is a distinct entity with features of multiple myeloma (MM) and Waldenstrom's macroglobulinemia (WM). The malignant cells in IgM myeloma have a distinctive chromosomal translocation that differentiates them from WM. These cells are postgerminal-center in origin with isotype-switch transcripts. They appear to be arrested at a point of maturation between that of WM and MM. Preliminary data indicate that a pattern of osteoclast-activating factor and osteoprotegerin expression similar to that observed in classic MM is present in IgM myeloma. Additional studies on patients with this rare tumor may provide further insight into the pathogenesis of bone disease in plasma cell dyscrasias.
免疫球蛋白(Ig)M 骨髓瘤是一种具有多发性骨髓瘤(MM)和华氏巨球蛋白血症(WM)特征的独特疾病实体。IgM 骨髓瘤中的恶性细胞具有独特的染色体易位,这使其与 WM 相区别。这些细胞起源于生发中心后阶段,带有同种型转换转录本。它们似乎在 WM 和 MM 之间的成熟阶段停滞。初步数据表明,IgM 骨髓瘤中存在与经典 MM 中观察到的类似的破骨细胞激活因子和骨保护素表达模式。对这种罕见肿瘤患者的进一步研究可能会为浆细胞发育异常中骨病的发病机制提供更深入的见解。